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Summary 
Hematopoietic cells present in the liver in early human fetal ife were characterized by phenotypic 
analysis using a broad panel of monoclonal ntibodies. Expression of very late antigen 4 and 
leukocyte function-associated antigen 3cell adhesion receptors and 4F2 cell activation molecules 
was found in all fetal iver hematopoietic cells before acquisition of T cell-, B cell-, or myeloid- 
specific surface markers, and before the time ofintrathymic colonization. Molecular studies howed 
that expression of the interleukin 2 receptor ~ (IL-2RB) also occurred in the embryonic liver 
at this early ontogenic stage. In contrast, no expression ofIL-2RoL or IL-2 transcripts was found 
in fetal iver cells, whereas transcription of the IL-4 gene was detected in a small fetal iver cell 
subset. Putative T cell precursors were identified among the hematopoietic fetal iver cells by 
the expression of genes encoding the 3/, ~, 6, and ~" invariant chains of the CD3-T cell receptor 
(TCR) complex. However, no transcription fthe polymorphic c~ and ~ TCR genes was detected. 
Functional in vitro assays further demonstrated that fetal iver hematopoietic cells from those 
early embryos were capable of proliferating in response to T cell growth factors, including IL-4 
and IL-2. However, whereas IL-4-induced proliferation paralleled the appearance in vitro of 
CD45+CD7-CD4 'hm cells expressing the CD14 myeloid antigen, as well as of CD34 + primitive 
hematopoietic progenitors, differentiation into CD45 + CD7 + CD8 + CD3- immature T cells was 
observed when using II.-2. Moreover, coculture with thymic epithelial cell monolayers provided 
additional evidence that early fetal iver hematopoietic cells may include very primitive T cell 
precursors, which were able to differentiate in vitro into TCR oL/~/+ mature T cells. Therefore, 
our results indicate that, after triggering of the T cell-specific maturation program in primitive 
fetal iver hematopoietic progenitors, pecific signals provided intrathymically b  epithelial cells 
may fulfill the requirements todrive terminal differentiation fprethymically committed T cell 
precursors. 
D uring human fetal development, hematopoietic stem cels home to the fetal liver at 5-6 wk of gestation. The 
liver then becomes, until week 24, the major site of hemato- 
poiesis in humans, supporting the proliferation of progen- 
itor cells for all hematolymphoid series (including the ery- 
throid, myelomonocytic, and lymphoid lineages) (1, 2). 
Differentiation of fetal liver progenitors along a particular 
hematopoietic lineage is further dependent upon epigenetic 
influences provided by specific ellular microenvirouments. 
The development of immunocompetent T lymphocytes 
occurs primarily in the embryonic thymus (3, 4). At 8.5-10 
wk of gestation, hematopoietic precursors migrating from 
the fetal iver colonize the thymic rudiment (5), where they 
undergo a complex series of differentiation events leading to 
the expression of the TCR-CD3 complex (6, 7). Efficient 
performance of this complex program appears to be depen- 
dent upon cellular interactions between developing thymo- 
cytes and thymic stromal components (i.e., epithelial cells, 
macrophages, fibroblasts, and dendritic ells) (8). In addition, 
the coordinated production of multiple growth factors by both 
hematopoietic and stromal thymic ells throughout ontogeny 
may be critically involved in the T cell differentiation process 
(6, 9). 
Less is known, however, about he developmental programs 
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that may operate at very early stages in fetal T cell ontogeny 
to drive hematopoietic stem cell differentiation towards the 
T cell lineage. Considerable insight into this process has been 
gained by the identification of fetal hematopoietic CD7 + 
cells as the earliest prethymic T cell precursors (5, 10, 11). 
Phenotypic studies have shown that cells expressing the CD7 
T cell marker were present in the fetal liver before hemato- 
poietic cell colonization of the epithelial thymic rudiment 
(10, 11), and concentrated in the upper thorax mesenchyme 
just before and during the time ofT cell precursor migration 
to the embryonic thymus (11). Functional studies further 
demonstrated that CD7 + cells from fetal liver and thorax 
were enriched for T cell precursors capable of giving rise to 
mature T cells (11), indicating that T cell commitment events 
may occur very early in human ontogeny. Nonetheless, the 
observation that both prethymic and intrathymic CD7 + 
cells can also be driven to undergo myeloerythroid differenti- 
ation by particular combinations of cytokines (11, 12) sug- 
gested that certain subsets of CD7 + cells are not irrevers- 
ibly committed to the T cell lineage (7). 
In the present report, phenotypic and molecular studies 
were performed to determine whether prethymic differentia- 
tion events of human T cells might be identified in primitive 
hematopoietic precursors from the early embryonic liver, be- 
fore T cell marker expression. In addition, functional studies 
were done to analyze the differentiation requirements of the 
putative T cell precursors present in the liver in early human 
fetal ife. Our results howed that T cell-specific maturation 
events, including the expression of genes encoding the 3', 8, 
e, and ~" invariant components of the CD3-TCR complex, 
were initiated early in ontogeny in fetal liver hematopoietic 
precursors that lacked CD7 molecules but expressed very late 
antigen 4 (VLA-4) 1 and leukocyte function-associated an- 
tigen 3 (LFA-3) cell adhesion receptors. Initial differentiation 
of these primitive fetal iver hematopoietic progenitors along 
the T cell lineage was demonstrated by their ability to pro- 
liferate in response to rib2 and to give rise in vitro to CD7 + 
CD8+CD3 - immature T cells. In addition, fully differen- 
tiated CD3-TCR c~/3 + mature T cells were obtained after 
coculture with thymic epithelial cell monolayers plus IL-2. 
Therefore, our results provide evidence that specific signals 
delivered by the thymic epithelium are required to drive ter- 
minal differentiation of prethymically committed fetal liver 
T cell precursors. 
Materials and Methods 
Cell Samples. Human fetal tissues were obtained after legal ter- 
mination of pregnancy. Gcstational ge determined by crown/rump 
length, foot length, and menstrual records (13) ranged from 7 to 
22 wk. Infant thymus samples were obtained from 1 too-old to 
3 yr-old patients undergoing corrective cardiac surgery. Cell sus- 
pensions were obtained from thymus, spleen, and liver samples, 
and mononuclear cells were separated bycentrifugation over Ficoll- 
Hypaque (Pharmacia, Uppsala, Sweden), through which mature 
1 Abbreviations used in thispaper: TEC, thymic epithelial cells; VLA, very 
late antigen. 
red blood ceils and hepatocytes sedimented. The cells at the inter- 
face were then washed three times in KPMI 1640 (Gibco, Paisley, 
Scotland) containing 2mM L-glutamine, 10 mM Hepes, 100 U/ml 
penicillin, 100 mg/ml streptomycin, and 10% heat-inactivated FCS 
(Gibco) (complete medium). 
Intrathymic T cell precursors, referred to as pro-T cells (14), were 
isolated from neonatal thymi by consecutive treatments with anti- 
CDla (Nal.34), -CD4 (HP2/6), -CD8 (B9.4), -CD3 (SPV-T3b), 
and -CD2 (Leu-5b) mAbs plus rabbit complement (scra Labs Ltd., 
Sussex, UK), as described previously (14). After Ficoll-Hypaque 
centrifugation, recovered viable cells were treated again, in one step, 
with a cocktail of the indicated mAbs and incubated 30 rain at 
4~ with magnetic beads coated with affinity-purified sheep 
anti-mouse IgG (Dynabeads M-450; Dynal, Oslo, Norway) fol- 
lowing manufacturer's recommendations. This procedure allowed 
the isolation of a highly purified preparation of pro-T cells (>99% 
CD45 +, 50-95% CD7 § CDla-2-3-4-8-) (14, 15). 
Activated peripheral T cells were obtained after culture of PBMC 
in complete medium containing 1% PHA (Difco Laboratories, 
Detroit, MI) for 4 d. 
Quantitative Flow Cytometry. Flow cytometry studies were per- 
formed by direct or indirect immunofluorescence as described (14). 
Cells were incubated with saturating amounts of the corresponding 
mAb (Table 1) at 4~ for 30 rain, followed by two washes. FITC- 
conjugated F(ab')a goat anti-mouse IgG (Southern Biotechnology 
Associates, Inc., Birmingham, AL) was used as a second-step re- 
agent. For dual parameter analyses, cells stained following the de- 
scribed procedure, or directly labded with available FITC-coupled 
mAbs: FITC-GAPS.3 (Table 1) and FITC-OKT3, -OKT4, -OKT8 
(Ortho Diagnostic, Raritan, NJ), were further incubated either 
with biotin-conjugated mAbs (3A1, MAR-108) (Table 1) followed 
by PE-coupled streptavidin (Southern Biotechnology Associates, 
Inc.) or with available PE-coupled mAbs (T11-tLD1; Coulter Im- 
munology, Hialeah, FL; PE-I.cu-4, PE-Leu-2a, PE-Leu-3a; Becton 
Dickinson & Co., Mountain View, CA). Irrelevant isotype-matched 
mAbs (Becton Dickinson & Co.) were used as negative controls. 
Quantitation of the surface staining of 104 viable ceils was per- 
formed using an EPICS Profile flow cytometer (Coulter Electronics, 
Hiahah, FL). Cells were considered positive for the tested antigen 
when fluorescence intensity was above the upper limit of the nega- 
tive control. The data were computed for graphic display using 
a program developed in our laboratory (46). 
Fetal Liver Cultures. Freshly isolated fetal liver mononuclear cells 
(2 x 106) were cultured in 24-well macroplates (Costar, Cam- 
bridge, MA) at 106 cdls/ml in complete medium alone, or in com- 
plete medium containing optimal mitogenic doses of either rIL-2 
(10 nM) (Hoffman-La Roche, Basel, Switzerland) or rib4 (1 nM) 
(Sandoz, Basel, Switzerland); or were cocultured with monolayers 
of the ET-VII thymic epithelial cell line (2 x 104 cells/well) in 
complete medium with or without 10 nM rIL-2. 
Preparation of Thymic Epithelial Cell Monolayers. Monolayers of 
thymic epithelial cells were prepared from neonatal or fetal thymi 
as previously described (47). The cultures were initiated in six-well 
plates (Costar) in D-valine-supplemented MEM (Gibco) containing 
2 mM L-glutamine, 10 mM Hepes, 100 U/ml penicillin, 100 mg/ml 
streptomycin, and 10% FCS (D-valine medium). D-valine was used 
to hinder the growth of fibroblasts without affecting that of epi- 
thelial cells (49). After 5-7 d, cells were incubated at 37~ for 
2 d in D-valine medium containing 5 ~g/ml mycophenolic acid 
(Sigma Chemical Co., St. Louis, MO) to further eliminate hema- 
topoietic cells. The cell monoh-yen were subsequently removed from 
the wells every 7 d by treatment with 1.5 ml/weU Puck's-modified 
solution containing trypsin and EDTA (Gibco) and, after washing, 
20 Human Fetal T Cell Ontogeny 
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ceUs were propagated inD-valine medium. Functional and pheno- 
typic studies of epithelial cells growing under these culture condi- 
tions were performed after 2-3 too. For phenotypic analyses, epi- 
thelial ceils, either untreated or treated with digitonin (0.005%) 
as previously described (49), were subjected to indirect immuno- 
fluorescence staining by using the fonowing mAbs: AE-3, anti-high 
molecular weight basic keratins; TE-3A, anti-cortical thyrnic epi- 
thelium; and TE-4, anti-subeapsular cortical and medullary epi- 
thelium (8), kindly provided by Dr. B. F. Haynes (Duke University 
Medical Center, Durham, NC); RFD4, anti- medullary thymic 
epithelium (50), the kind gift of Dr. G. Janossy (Royal Free Hos- 
pital School of Medidne, London, UK); TE-7, anti-mesoderm- 
derived thymic epithelium (8) (Scra Labs); TS 2/9, anti-LFA3 (41), 
kindly donated by Dr. F. Sanchez-Madrid (Hospital de la Princesa, 
Madrid, Spain); and W6/32, anti-MHC chss I (A, B, C) (43). 
eDNA Preparation. Total cellular RNA was isolated from fetal 
and adult tissues by the acid phenol procedure (51). The integrity 
of mKNA was verified by optical density, ethidium bromide 
staining, and Northern blot hybridization after electrophoresis on 
formaldehyde-agarose gels,as described dsewhere (14). Reverse tran- 
scription of total KNA (5 tLg) into single-strand cDNA was per- 
formed using AMV reverse transcriptase and oligo(dT)ls primers 
(Boehringer Mannheim GmbH, Mannheim, Germany), according 
to the manufacturer's ecommendations. 
PCR Analysis. PCR amplifications (52) were performed with 
5% of each eDNA sample, in a 100-#1 reaction volume containing 
2.5 U ofTaq polymerase (Perkin Elmer Cetus, Norwalk, CT) and 
100 pmol of each of the two gene-specific primers. DNA was 
amplified by 30 cycles of 940C for 1 rain, 550C for 1 rain, and 
720C for 1.5 rain, in a thermal cycler (Perkin Elmer Cetus). PCR 
amplifications of genes encoding the 3', #, e, and ~" chains of the 
CD3-TCR complex and IL-2Rot and IL-21~ were performed 
by using the following oligonucleotide primers: 5' CD3-3,, 
5 ' -CAGGAAT~~CACGCTIT IGC-3 ' ;  3' CD3-T, 
5'-CAGAAGCTTTTCCCCAATAGGTGGCGC-3'; 5' CD3-~, 
5'-TTCCGGTACCTGTGAGTCAGC-3'; 3' CD3-8, 5'-GGTACA- 
GTTGGTAA_q'GC~TGC-3'; 5'CD3-e, 5'-GAAATGC~TGGTAT- 
TACACAGACACC-3'; 3' CD3-6, 5'-GC_~CTCTGTCAACATI~- 
ACCCAGTCC-Y; 5' TCR-~', 5'-CAGAAGCTTC'IV_,CCTCAGC- 
CTCIV~CT-3'; 3' TCR-~', 5'-TATGAAT/'CGCCTTTGAGTGG- 
TGAAAT-3'; 5' Ib21k~, 5'-TTCAC'IV_~GGCCGCTGGTCCCA- 
AGGGTCAG-3'; 3' IL-2Rot, 5'-GCTTGCCTGAGGCTTCTCT- 
TCACC'IGGAAA-Y; 5' IL-21~, 5'-CCAGCTGAGCTCAGAGC- 
ATGG-3'; 3' IL-21~, 5'-CCAAGTGAGTTGGGTCCTGACC-3'. 
To avoid unspliced mRNA or DNA amplification, each primer 
of every pair was located in different exons. Ib2 and IL-4 transcrip- 
tion studies were performed by the MAPPing TM technique 
(Clontech Laboratories, Inc., Palo Alto, CA), using appropriate 
oligonuchotide primers (Clontech Laboratories, Inc.). Previously 
reported egenerate primers (53), developed on the basis of the 
conserved sequences atthe 5' end of human V~ and V~ gene seg- 
ments, in combination with either Ccz or C~ primers, enabled the 
amplification of all known human Vot and V~ chain TCIk genes. 
As described (53), these sets of primers also proved successful in
the amplification and cloning of VDJ regions for which no prior 
sequence data are known, indicating their general applicability in 
TCR gene expression studies. 
Equivalent amounts of eDNA among different samples could 
be estimated by comparable capacity to act as substrate for 
amplification directed by ~-actin gene-specific primers (Clontech 
Laboratories, Inc.) at 15, 20, and 30 cycles of amplification. Titra- 
tion of cycle number allowed us to perform densitometric analyses 
of the ~-actin amplifications among different eDNA samples under 
nonsaturating conditions. Thus, since all samples analyzed for a 
given pair of primers were processed simultaneously, comparisons 
could be made for the expression of a particular gene in different 
cell samples. The B-actin control shown in Fig. 2 applies for studies 
shown in both Figs. 2 and 4, which were performed on exactly 
the same DNA samples. The specificity of the amplified products 
was demonstrated bySouthern blot hybridization. PCR products 
(10 #1) were run on 1.5% agarose gels, transferred tonylon mem- 
branes, and hybridized as described elsewhere (14) using the eorre- 
sponcling ene-specifie probes. The CD3-e (54) and CD3-# (55) 
probes were the kind gift of Dr. C. Terhorst (Dana Farber Cancer 
Institute, Boston, MA), and the CD3-T (56) and TCR-~" (57) probes 
were kindly provided by Drs. M. J. Crumpton (Imperial Cancer 
Research Foundation, London, UK) and R. D. Klansner (National 
Institutes of Health. Bethesda, MD), respectively. The IL-2 (58) 
and IL-2tL8 (59) probes were generously provided by Dr. T. 
Taniguchi (Osaka University, Osaka, Japan), and the IL-4 (60) and 
IL-2Rot (61) probes were the generous gift of Drs. K. Arai (DNAX 
Research Institute of Molecular and Cellular Biology, Palo Alto, 
CA) and "1". Honjo (Kyoto University, Kyoto, Japan), respectively. 
Spedfie Col (62) and CB (63) probes were kindly provided by Dr. 
T. Mak (The Ontario Cancer Institute, Toronto, Ontario, Canada). 
In Situ Hybridization. Freshly isolated hematopoietic fetal iver 
cells (10 s cells/slide) were subjected to in situ hybridization by 
using eDNA probes hbeled with digoxigenin-11-dUTP (Boehringer 
Mannheim), as previously described (46). Antidigoxigenin anti- 
bodies conjugated to alkaline phosphatase (Boehringer Mannheim) 
were used for the immundogical detection according to the 
manufacturer's recommendations. The number of positive ceils was 
determined over background labeling detected after hybridization 
of fetal liver cells with an irrelevant mouse Ig probe (]11). The CD3-e 
(54), CD3-/J (55), CD3-T (56), TCR-f (57), IL2Ro~ (61), IL-2R~ 
(59), Ib2 (58), and 1/.,4 (60) eDNA probes used in this study have 
previously proved successful in the in situ hybridizations of in- 
trathymic T cell precursors and mature T cells, whereas background 
labeling was detected with mouse B cells (46, and our unpublished 
results). 
II.,2 Binding Assays. Aliquots of freshly isolated fetal iver ceils 
(2 x 107) were extensively washed and treated for 3 rain at 4~ 
with 0.15 M NaC1, 0.1 M glycine (pH 4) and washed again three 
times. Ceils (106) were then incubated with serial dilutions (1 pM 
to 25 nM final concentration) of mI-labeled IL-2 (Amersham 
Corp., Amersham, UK) for 1 h at 4~ as previously described 
(15). Specifically bound and free 12SI-labded IL-2 was determined 
by solid scintillation counting. The calculated values for the dis- 
sociation constant and the number of binding sites per cell were 
derived by Scatchard computer analysis of equilibrium binding data, 
according to Munson and Rodbard (64), assuming auniform dis- 
tribution of sites. The data were corrected for nonspecific binding 
of IL-2, determined in the presence of a 250-fold molar excess of 
unlabded rlL-2, and for the loss ofligand binding activity incurred 
during the IL-2 binding procedure. 
Results 
Phenotypic Characterization f Primitive Hematopoietic Cells 
in Human Fetal Liver: Early Ontogenic Expression of VLA-4 
and LFA.3 Cell Adhesion Molecules. To address the ontogeny 
of hematopoietic cells in the human fetal liver, cytofluoro- 
metric analyses were performed in freshly isolated mononuclear 
cells from different 7-22-wk-old fetal iver samples, using the 
panel of mAbs listed in Table 1. These studies revealed that 
21 S~nchez et al. 
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Tab le  1. mAbs Used for the Phenotypic Analysis of Hematopoietic Cells in Human Fetal Samples 
Differentiation Antigen 
cluster (CD)* mAb recognized Reference 
CDla Nal.34,T6t T6/HTAl,gp49 16,17 
CD2 OKTll,SLeu5b,UTllt Tll/LFA2,gp50 18,19 
CD 3 SPV / T3b, OKT3,SLeu411 T3, gp26,20,16 20- 22 
CD4 I',IP2/6,OKT4,SLeu3a I~ T4,gp59 23-25 
CD5 OKTI,SLeulll Tl,gp67 20,26,27 
CD7 3A1 'i gp40 28 
CD8 B9.4, O KT8, SLeu2al1 T8, gp32 17,24,29 
CDllb Molt C3biR,gp155/95 30 
CD13 My7t gp150 31 
CD14 Mo2* gp55 30 
CD16 Leullcll FcRIII,gpS0-65 32 
CD19 B4* gp95 33 
CD20 BI* p37/32 34 
CD25 MAR- 108 IL-2R~/Tac,gp55 25 
CD28 9.3"* T44,gp44 35 
CD29 Ts2/16 VLA-/~,gp130 36 
CD34 HPCAlll gp105-120 37 
CD38 OKT10S T10,p45 17 
CD45 GAP8.34 T200/LCA,gp180-220 38 
CDw49d HP2/1 VLA-4,gp150 39 
CD57 Leu711 HNK-l,gp110 40 
CD58 Ts2/9 LFA3,gp40-65 41 
CD71 OKT9S T9/TfR,gp180 17 
- 4F21 gp120 42 
- W6/32 ~ HLA A,B,C;gp40 43 
- anti-HLA-DR II HLA-DR;gp29/34 44 
* From references 44a and 45. 
* Coulter Clone. 
$ Ortho Diagnostic (Raritan, NJ). 
U Becton Dickinson & Co. 
American Type Culture Collection (Kockvilh, MD). 
"* New England Nuclear (Boston, MA). 
none of the fetal livers analyzed from 7 to 8 wk of gestation 
(the earliest ime examined) contained cells expressing T cell 
markers on the ceil surface, as assessed by staining with mAbs 
specific for CDla, CD2, CD3, CD4, CD8 (Table 2), CD28, 
or IL,21Lc~ (CD25) (data not shown). We observed reactivity 
of these samples neither with mAbs that recognize the early 
T lineage molecule CD7 (Table 2) nor with antibodies specific 
for myeloid (CD13, CD14), NK ceil (CDllb, CD16, CD57), 
or B ceil (CD19, CD20) differentiation antigens (data not 
shown). Similarly, CD34 molecules (normally expressed on 
primitive hematopoietic progenitors) were rarely found in the  
fetal liver at this early gestational ge, although CD34 + cells 
were  observed in older liver and spleen samples (Table 2). 
Expression of the pan-leukocyte molecule CD45 was detected 
on only a small, but measurable, fraction (0-8%) of fetal iver 
22 Human Fetal T Cell Ontogeny 
ceils before 9 wk of gestation. The proportion of CD45 § 
cells in each particular sample was slightly higher than the 
number of cells reactive with an anti-HLA heavy chain-specific 
mAb (0-4%), while expression of class II MHC molecules 
could not be detected (Table 2). With increasing gestational 
age, the percentage of ceils in the fetal liver expressing the 
CD45 marker and class I MHC molecules gradually rose to 
41 and 22%, respectively, at week 22 of gestation (the latest 
gestational age examined). Surface expression of the CD45 
leukocyte-associated marker paralleled the acquisition of the 
CD7 T cell molecule, which was detected on 0.5-6% of fetal 
liver cells at weeks 11-13, and reached 13% at week 22. Very 
few CD7 § ceils, however, expressed CD3 molecules on the 
membrane (Table 2). Mature T cells progressively increased 
in fetal spleen and thymus following the sequence of appear- 
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Table 2. $ugCace Expression of Lyraphoid Antigens on Hematapoietic Cells from Human Fetal Tissues 
Fetal tissue 
Liver Thymus Spleen 
Antigen 7-8 wk* 11-13 wk 22 wk 22 wk 22 wk 
CD45 4.5 + 3.5 (6) 10.2 _+ 4.6 (4) 33.0 + 8.5 (3) 95.0 + 2.0 (3) 47.0 (1) 
CD34 <0.1 (3) 0.5 • 0.3 (2) 6.0 (1) ND 11.0 + 5.0 (2) 
CD7 <0.1 (6) 3.2 + 2.7 (3) 13.0 (1) 87.5 (1) ND 
CDla <0.1 (6) <0.1 (3) 3.0 _+ 2.0 (3) 82.0 + 5.0 (3) 1.5 + 0.3 (3) 
CD2 <0.1 (6) 1.5 • 0.4 (3) 8.5 + 2.5 (3) 96.0 + 2.0 (3) 15.5 + 4.5 (3) 
CD3 <0.1 (6) 1.3 + 0.2 (3) 5.1 • 1.1 (4) 71.5 • 4.5 (3) 12.5 • 5.0 (3) 
CD4 <0.1 (6) <0.1 (3) 7.5 + 4.0 (4) 70.5 • 8.0 (3) 8.5 • 2.0 (3) 
CD8 <0.1 (6) <0.1 (3) 6.5 + 2.0 (4) 82.5 • 4.5 (3) 7.5 • 2.0 (3) 
MHC class I 2.3 • 1.3 (5) 11.5 • 4.5 (3) 15.0 • 7.0 (3) 17.5 + 2.5 (2) 19.5 • 2.5 (2) 
MHC class II 0.5 • 0.3 (4) 4.4 • 2.8 (3) 8.0 • 3.0 (2) 1.0 • 0.5 (2) 9.5 • 1.5 (2) 
Values are expressed asthe mean + SEM of the percent of nucleated positive cells determined byflow cytometry. Number of fetal samples tested 
is in parentheses. 
* Gestational ge (wk) was determined by crown/rump length, foot length, and menstrual records. 
ance of CD7 + T cell precursors in fetal liver. As shown in 
Table 2, a phenotypic distribution similar to that of the neo- 
natal thymus was observed in fetal thymi at week 22, and 
both mature B and T cells were detected in the spleen at this 
gestational age. 
In spite of the very low proportion of liver cells that ex- 
press conventional leukocyte markers in early fetal life, 4F2 
molecules, commonly expressed on rapidly dividing and ac- 
tivated cells, were detected on most (>95%) liver cells from 
as early as 7-8-wk-old embryos. Expression of transferrin 
receptors (Tfr, CD71) was also detected on a significant frac- 
tion (75-90%) of fetal liver cells (Fig. 1). Up to 50% of the 
fetal liver cells were in the S or G2 + M phases of the cell 
cycle (data not shown), which correlated with their activa- 
tion/proliferation surface phenotype. Surprisingly, amajority 
of hematopoietic fetal liver cells (>99%) at this gestational 
age also showed high levels of expression of different cell adhe- 
sion receptors. As shown in Fig. 1, LFA-3 (CD58) and the 
B1 subunit of the integrins (VLA-~, CD29) were detected 
in virtually all fetal iver cells. The expression of CD29 directly 
parallded that of the VLA-4 (CDw49d) member of the/31 
integrin subfamily (Fig. 1), whereas the expression of other 
~1 integrins, such as VLA-1, was undetectable (data not 
shown). 
Prethymic Transcription fGenes Encoding the % d, e, and ~" 
Invariant Chains of the CD3.TCR Complex in the Early Human 
Embryonic Liver. To analyze whether T cell-spedfic matu- 
ration events can occur in the human fetal liver before the 
acquisition of conventional T lineage markers, we studied 
the expression of genes coding for the CD3-TCR complex 
molecules in hematopoietic cells present in the liver from as 
early as at 8 wk of gestation, when no hematopoietic cell 
precursors have yet colonized the thymic rudiment. Transcrip- 
23 S~nchez et al. 
tion of genes encoding the % 8, 6, and ~" invariant compo- 
nents of the CD3-TCR complex was assessed by the PCR 
technique (52) (Fig. 2). Aliquots of single-strand cDNAs syn- 
thesized from similar amounts of total RNA obtained from 
freshly isolated cells were amplified by using specific oligo- 
Z 
"n 
0 
~ TROL 
TfR 
4F2 
LFA3 
VLA-4  
10 ~, ~2 10: )3 
LOG FLUORESCENCE INTENSITY {a. tJ.} 
Figure I. Expression of activation antigens and adhesion molecules on 
early human fetal liver hematopoietic ceils. Freshly isolated 8-wk fetal liver 
cells were stained with the indicated mAbs followed by FITC-conjugated 
goat anti-mouse F(ab')2 IgG. The number of positive ceils (98% 4F2 +, 
82% Tfr + , >99% LFA3*, 98% VLA-~J +, 97% VLA-4 +) was deter- 
mined over background staining observed with irrelevant mAbs used as 
negative controLs, Results are xq~.-sentative of five independent x']:~-iments. 
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Figure 2. Expression of genes encoding the % ~, e, and ~" invariant 
chains of the CD3-TCR complex in human fetal liver hematopoietic cells. 
Amplification of identical amounts of eDNA obtained from the indicated 
RNA samples was performed using CD3-% CD3-~, CD3-e, and TCR-~" 
chain-specific oligonucleotides. PCR-amplified products (10/A) were sub- 
jected to Southern blot hybridizations using gene-specific probes. Films 
were exposed forI-6 h and 1-4 d (left and right), respectively. The capacity 
ofcDNA generated from RNA to be amplified by PCR was in every case 
tested first by use of 3-actin-specific primers andsubsequent hybridization 
with a 3-actin probe. 3-actin films were exposed for 30 rain (left and right). 
Use of the 1-kb ladder marker indicated that products detected were of 
the expected size. 
nudeotide primers (see Materials and Methods). Checking 
of equivalence of cDNAs was assessed by use of specific primers 
for the/3-actin gene (Fig. 2), as described in Materials and 
Methods. All primer combinations failed to amplify a product 
when irrelevant eDNA (from mouse hybridoma X63) was 
used, or when eDNA was omitted from the reaction. The 
specificity of amplification was determined by further elec- 
trophoresis, blotting, and hybridization f amplified prod- 
ucts with specific probes. 
As shown in Fig. 2, CD3-3,-, CD3-~-, CD3-e-, and TCR- 
~'-specific bands were detected in the following samples: (a) 
Jurkat T cells and PHA-activated peripheral Y cell blasts (PHA- 
B), induded in the study as positive controls; (b) mature 
CD3 + thymocytes and CD7+CD3 - intrathymic T cell 
precursors (referred to as pro-T cells; reference 14), obtained 
from a 6-too-old thymus; and (c) fetal thymus and spleen from 
a 22-wk-old embryo. In addition, expression of genes encoding 
all ~,/~, e, and ~" invariant chains of the CD3-TCR complex 
was dearly evident in the fetal liver at all tested gestational 
times (8-22 wk), although less intense PCR signals requiring 
longer film exposures were observed in the earliest (8-11-wk) 
Figure 3. Analysis of the expression ofTCR a and TCK ~ IkNA tran- 
scripts in human fetal hematopoietic tissues. Equivalent amounts of eDNA 
obtained from the indicated sources were PCK amplified using pan Va 
or pan V/3 primers, in combination with Co~ or CB gene-specific primers, 
respectively. Southern blot hybridization of PCK amplifications was then 
performed using Ca or C]3 probes. Exposure to film was for I and 2 h, 
respectively. ~-actin gene PCK amplifications ofthe expected size verified 
the integrity of eDNA samples. 
fetal liver samples (Fig. 2). Comparable results were ob ained 
with independent RNA preparations from the same fetal 
sample, or from different samples at equivalent ontogenic 
stages. Parallel analyses of CD3-TCR gene xpression carried 
out by in situ hybridization independently confirmed the data 
derived by PCR (see below). Our results, therefore, provide 
molecular evidence that at early ontogenic stages, when T 
lymphoid markers are undetectable on the cell surface, the 
transcription of genes encoding the 3', 6, and ~ chains of the 
T cell-specific CD3 complex and the TCR-assoeiated ~"chain 
has already been initiated in the human fetal liver in putative 
prethymic T cell precursors. 
In contrast to the early ontogenic expression observed for 
the genes encoding the invar/ant components of the CD3- 
TCR complex, no rearrangement of genes coding for the 
polymorphic a and/~ chains of the TCR could be detected 
by Southern blot hybridization i  the 8-wk-old fetal liver 
samples studied. Neither did we find expression f functional 
TCR ce and TCR 13 RNA transcripts in those samples by 
Northern blotting (data not shown). To confirm these nega- 
tive results, functional V-(D)-J-C rearrangements wer  sought 
by the use of a highly sensitive PCR technique proved to 
detect ransiently expressed rearranged genes in v ry small 
24 Human Fetal T Cell Ontogeny 
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blot hybridization (Fig. 4). As described in Materials and 
Methods, equivalence in the amount ofcDNA could be esti- 
mated by their comparable capacity to act as substrate for 
amplification directed by fl-actin primers. This control is 
shown in Fig. 2. As expected, these studies howed that high 
levels of I1.-2 transcripts were expressed in activated periph- 
eral T cells, as well as in neonatal intrathymic pro-T cells, 
but not in CD3 + mature thymocytes (Fig. 4). Strong 
specific bands were also detected in the fetal thymus and fetal 
spleen samples analyzed at 22 wk of gestation, whereas a weak 
hybridizing band was detected in the liver at this gestational 
age (Fig. 4). By contrast, no IL-2 transcripts could be de- 
tected in the liver from 8-wk- and 11-wk-old fetuses (Fig. 
4), even after 60 cycles of amplification and upon long (10 d) 
exposure time (data not shown). This suggests hat IL-2 gene 
expression detected in liver and spleen at 22 wk most prob- 
ably reflected recirculating intrathymic precursors seeding those 
peripheral organs. In addition, IL-4-gene xpression was de- 
tected in all 8-, 11-, and 22-wk-old fetal iver samples exam- 
Figure 4. Cytokine gene xpression in human fetal hematopoietic tissues. 
cDNA obtained from the indicated samples was PCK amplified using IL.2, 
IL4, II..2Rot, and IL-2RB gene-specific primers. Amplified products were 
then subjected to Southern blot hybridization using ene-specific probes. 
Films were xposed for 1-3 d. cDNA sample integrity and checking of 
equivalence of cDNAs was assessed byfl-actin gene amplifications. This 
control is shown in Fig. 2 in a different order. 
percentages of cells in embryonic tissues (65). As described 
in Materials and Methods, amplifications were performed by 
using pan Vot or pan V3 primers pecific for all human Vot 
or Vfl gene families, in concert with either Cox or CB 
gene-specific primers (53), and followed by blotting and hy- 
bridization either with Cc~ or Cfl gene-specific probes. The 
results confirmed the absolute lack ofexpression of both rear- 
ranged TCR r and TCR/3 genes in the fetal liver by 8 wk 
of gestation (Fig. 3). As a negative control, TCR transcripts 
were also undetectable in the lymphoblastoid B cell line JY. 
In contrast, both c~ and/3 TCR gene transcripts were clearly 
evident in the liver, and strongly expressed in the thymus 
and spleen from a 22-wk-old embryo, as well as in CD3 + 
neonatal thymocytes (Fig. 3). Identical results were obtained 
independently of the amount of PCK products loaded, and 
upon longer film exposures (10 d; data not shown). 
Developmental Regulation of Cytokine/C2/tokine Receptor Gene 
Expression. Studies performed in the mouse embryo have 
shown that the genes coding for certain cytokines and their 
receptors, particularly I1.-2 and IL-4, are activated in vivo in 
the fetal thymus during early T cell development. Similar 
ontogenic studies have not been performed in humans as yet. 
Thus, cDNA samples identical to those used for Fig. 2, were 
amplified by PCK with appropriate oligonucleotide primers, 
and the amplified products were further analyzed by Southern 
Figure 5. Expression f CD3 and IL-21~ transcripts in human fetal 
liver hematopoietic cells. Cytocentrifuge pr parations of freshly isolated 
8-wk-old fetal liver cells (105 cells/slide) were hybridized in situ with 
cDNA digoxigenin-11-dUTP-labeled probes specific for the genes encoding 
the e (.4), 8 (B), 3, (C), and ~'(D) invariant chains of the CD3-TCK com- 
plex, and for the IL.2Ka (E) and IL-2RB (F) genes. An irrelevant mouse 
Ig probe 011) was included as negative control (G). Representative f elds 
are shown (• 440). 
25 S~nc.hez et al. 
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ined; as well as in fetal thymus, fetal spleen, and neonatal 3.00- 
pro-T cells, but not in mature thymocytes (Fig. 4). 
Parallel studies also showed that expression of the gene 
coding for the light chain of the II.-2R (IL-2Rct; p55, Tac) ~ _~ 2.40- 
was not detectable in the fetal liver at any gestational ge, ~ 2.o0_ 
neither in the early intrathymic pro-T cell subset, nor in ma- _~ o ture thymocytes (Fig. 4), independendy of the amount of 
PCR product loaded, and even upon long exposure times. ~ 1.4o_ 
Weak specific bands were observed, however, in fetal thymus ~ l o0_ 
and spleen, while high levels of Ib21kct ranscripts were pro- ca z 
duced in activated peripheral T cells. Expression of the gene 
encoding the heavy IL-2R chain (IL-2RB; p75) was observed m 0.40_ 
in all fetal and adult tissues analyzed, including the youngest 
(8 wk) fetal liver samples (Fig. 4), and a similar pattern of 
expression was detected for the IL-4R gene (data not shown). 
In situ hybridization studies were next performed to ob- 
tain quantitative information on the expression of the ana- 
lyzed genes, and to determine whether the observed pattern 
of cytokine production and cytokine receptor expression could 
be selectively attributed to a single subset of hematopoietic 
fetal iver cells, particularly to putative T cell precursors. Ex- 
pression of genes encoding the e,/~, and 3' CD3 subunits 
was detected in 40 + 7, 35 + 5, and 15 +_ 5%, respectively, 
of hematopoietic cells within the 8-wk-old fetal iver, whereas 
~" gene transcription was restricted to 6-8% of the cells (Fig. 
5). As previously shown by PCR, no IL-2Rtx expression could 
be found in the embryonic liver by in situ hybridization (<1% 
of positive cells). In contrast, IL-2R/3 transcripts were de- 
tected in a high proportion (70 _+ 7%) of fetal liver cells 
(Fig. 5). Expression of IL-4 and IL2 genes was also found 
to be limited to 15-20 and <1%, respectively, of the cells 
(data not shown). These quantitative r sults indicate that at 
least a minor fraction of putative fetal iver T cell precursors, 
shown to transcribe the CD3-e and/or CD3-6 genes, may 
also express Ib2RB, but not Ib2Rtx or Ib2 transcripts. How- 
ever, similar crosscorrelation a alyses could not be performed 
for the Ib4 gene. 
Surface Expression of IL2P-43 Molecules on Hematopoietic 
Cells within the Early Human Embryonic Live~. The functional 
relevance of IL-2RB gene expression detected in the early em- 
bryonic liver was assessed at the protein level by IIr binding CD45 
assays performed in freshly isolated fetal liver cells. Because CD34 
of the low numbers of mononudear cells obtained from the CD7 
youngest available fetal iver samples, Ib2 binding assays were CDla 
carried out on hematopoietic cells from 13-wk-old fetal ivers. 
As shown in Fig. 6, Scatchard analysis of equilibrium binding CD2 
data obtained by using serial dilutions of 12SI-labeled human CD3 
rib2 (1 pM to 25 nM final concentration) indicated that fetal CD4 
liver cells displayed 1,605 intermediate-affinity (Ka, 936 pM) CD8 
IL-2 binding sites per cell (assuming a uniform distribution CD14 
of sites in all cells) (Fig. 6). However, since Ib2P~ transcripts IL-2gct 
were expressed at most in 70% of fetal liver cells, a higher 
number of II--2RB molecules per cell may be expressed by 
a subset of fetal liver cells. According to the observed lack 
of IL-2tkct transcripts, low and high affxnity IL-2Rs were not 
detected (Fig. 6). Therefore, Ib2RB is the chief IL-2 binding 
component expressed on the surface of hematopoietic fetal 
liver cells. 
0.00 
0 
~,Lo3- 
..J• 
c3~2_  Z o 
0 / 
FREE IL-2 (nM) 
QO 
I ~ I ~3 
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Figure 6. Expression of Ib2RB molecules on early human fetal liver 
hematopoietic cells. IL-2 binding assays were performed in fleshly isolated 
13-wk fetal iver cells incubated with serial dilutions (1 pM to 25nM final 
concentration) of lzSI-labeled II~2. The calculated values for the dissocia- 
tion constant and for the number of IL-2 binding sites were derived by 
Scatchard computer analysis of equilibrium binding data. Similar esults 
were obtained in three independent e~periments. 
Hematopoietic Cells Present in the Early Human Fetal Liver 
Contain Precursors of CD7+ CD8+ CD3- Immature T Cells. 
Fetal iver cells were next functionally assayed for their ability 
to proliferate to defined T cell growth factors. Thus, fleshly 
isolated mononudear cells from 8-wk fetal iver samples were 
cultured in vitro with either Ib2 or IL4; i.e., two lymphokines 
known to play a key role as growth factors for intrathymic 
Table 3. In Vitro Induction of T Cell Marker Expression 
on Human Cultured Fetal Liver Cells 
Culture Conditions 
Antigen - IL-2 IL-4 ET-VII IL-2 + ET-VII 
98 97 70 98 94 
ND 8 38 45 ND 
<0.1 94 5 63 53 
<0.1 <0.1 <0.1 <0.1 <0.1 
<0.1 12 <0.1 <0.1 45 
<0.1 <0.1 <0.1 <0.1 31 
27 dull <0.1 25 dull <0.1 30 h'isht + 9 dull 
<0.1 63 <0.1 <0.1 12 
ND 5 30 ND 9 
<0.1 3 <0.1 ND 47 
Shown are percentages of positive cells analyzed by flow cytometry. Freshly 
isolated 8-wk fetal liver cells (l(F/ml) were cultured (15 d) in medium 
alone or in medium containing either rlL-2 (10 nM) or rIL-4 (1 nM), 
or were coeukured with monohyers of the ET-VII thymic epithelial cells 
(2 x 104 cells/well) in medium either with (20 d) or without (15 d) 
10 nM rIL-2. Results are representative of three independent experiments. 
26 Human Fetal T Cell Ontogeny 
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T call precursors in both mice and humans (6). Although 
functional responses varied between different samples, a dose- 
dependent ceUular proliferation was repeatedly observed in 
cultures et up with either IL-2 or IL-4. To determine the 
phenotype of hematopoietic cells within the embryonic liver 
able to proliferate in response to these cytokines, the expres- 
sion of distinct differentiation molecules was next analyzed 
by flow cytometry after culture in the presence of optimal 
mitogenic doses ofrlL2 (10 nM) or rlL-4 (1 riM). A gradual 
increase in the expression of MHC class I and CD45 mole- 
cules was observed in both culture conditions, as well as in 
cultures devoid of exogenous lymphokines. CD45 + leuko- 
cytic ceUs arising in these cultures reached maximal levels 
(g98%) at days 8-15 (in five different experiments) (Table 
3). The acquisition of lineage-specific differentiation a tigens 
and the quantitative outcome of the progeny differed, how- 
ever, between IL-2- and IL-4-driven cultures. Upon culture 
with IL-2, acquisition of CD45 molecules parallded the ex- 
pression of the CD7 T cell marker and, thus, both molecules 
were coexpressed on most (94%) calls by day 15 (Table 3, 
and Fig. 7). In contrast, no CD7 expression was detected 
Figure 7. Hernatopoietic cells from 8-wk human fetal liver contain 
precursors ofCD7+CDS+CD3 - immature T cells. Freshly isohted 8-wk 
fetal liver cells displaying the phenotype shown in Table 2 were cultured 
with rib2 (10 nM) for 15 d. Two-color immunofluorescence a alyses were 
then performed using the following combinations of mAbs: FITC-GAPS.3 
(anti-CD45) and biotin-coupled 3A1 (anti-CDT) plus treptavidin; FITC- 
OKT8 (anti-CDS) and PE-Leu-3a (anti-CD4); FITC-OKT3 (anti-CD3) 
and Tll-RD1 (anti-CD2); and MiK-3I (anti-IL-21~) plus FITC-goat 
anti-mouse F(ab')2 IgG and biotinihted MAR-108 (anti-IL-2Ro~) plus PE- 
streptavidin. Identical results were obtained in three independent ex-
periments. 
27 S~nchez et al. 
in the absence of exogenous lymphokines, and rare (<5%) 
CD7 + cells were observed after supplementation with Ib4 
(Table 3). Interestingly, the lack of CD7 molecules in both 
culture conditions correlated with the acquisition of low levels 
of CD4 molecules (CD4 a~u) on a significant proportion 
(g30%) of CD45+CD7 - cells. These cells also expressed 
variable levels of CD14 molecules (Table 3), classically ad- 
scribed to the myeloid lineage. Rare CD4 aun and CD14 + 
cells were also observed at initial periods of culture in the 
presence of IL-2. However, the increase in CD7 molecules 
in IL-2 driven cultures paralleled a gradual decrease in 
CD14 + calls (Table 3). Special mention also has to be made 
of the differential expression of CD34 molecules, norrnally 
expressed on primitive hematopoietic stem cells, in cultures 
supplemented with IL-4 (38%) or II~2 (8%) (Table 3). 
Our functional data demonstrated that hematopoietic cells 
found in the fetal iver as early as 8 wk of gestation can give 
rise to cells of the T call lineage. This was further supported 
by the observation that acquisition of CD7 molecules was 
followed by the expression of low levels of CD2 and high 
levels of CD8 T cell antigens on 12 and 63%, respectively, 
of Ib2-cultured fetal liver cells, whereas CD2 + and CD8 + 
cells were not detected in cultures devoid of Ib-2 or in the 
presence of IL-4 (Table 3). It must be stressed, however, that 
the CD8 + T cell subset comprised large-sized blastic cells 
that did not include mature T ceils, since no expression of 
the CD3-TCR complex was detectable (Table 3, and Fig. 7). 
CD7 + CD8 ~ CD3- cells lacked the IL-2Rot (Table 3), while 
most cells in the culture (79%) were reactive with a recently 
available anti-Ib2R/J mAb (66) (Fig. 7). 
CD7- Hematopoietic Cells from 8-wk Fetal Liver Give Rise 
to TCR cr/~ § Mature T Cells in the Presence of Thymic Epi. 
thelium. The finding that CD7+CD8+CD3 - immature T 
cells, but not mature T lymphocytes, were derived from 
8-wk-old fetal liver hematopoietic precursors in IL-2-driven 
cultures led us to analyze whether additional costimulatory 
signals delivered in vivo within the thymic microenvironment 
were required to efficiently drive terminal differentiation of
primitive fetal liver T cell precursors into TCK-CD3 + ma- 
ture T cells in vitro. To this end, we prepared monolayers 
of thymic adherent stromal cells derived from neonatal and 
fetal thymi. Hematopoietic cells were depleted from these 
preparations by treatment with mycophenolic a id (see Ma- 
terials and Methods). After 3 mo of culture, stromal cell 
preparations were shown to be homogeneous for the expres- 
sion of cytokeratins recognized by the AE-3 mAb (>95% 
AE3 +), as well as for the lack of hematopoietic antigens 
(<0.1% T cell-, B cell-, or myeloid-specific markers) or 
fibroblast-specific markers (<5% TE-7+), with all these 
criteria supporting their thymic epithelial origin. The capacity 
of these thymic epithelial cells (TEC) to support T cell differen- 
tiation was assessed in vitro by coculturing freshly isolated 
8-wk fetal iver mononuclear cells with monolayers of estab- 
lished TEC. All experiments reported in this study were per- 
formed with a TEC preparation (ET-VII) that was homoge- 
neous for the expression of MHC class I and LFA,3 molecules 
and expressed both cortical and medullary thymic epithelium 
markers: 100% AE-3 +, 90% TE-4 +, 20% RFD4 +, 30% 
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TE-3 + , <1% TE-7 + . As assessed by PCR, ET-VII cells were 
also shown to transcribe the IblB, I1.3, Ib6, and II-7 genes, 
while transcription of I1.2 and I1.4 was not detected (data 
not shown). 
Fetal liver cells cultured in the presence of ET-VII epithe- 
lial cells without exogenous cytokine supplementation showed 
limited proliferative responses. Thishampered performing ex- 
tensive phenotypic analyses, although expression of CD45 
and MHC class I molecules could be detected in a major 
proportion of cultured cells (Table 3, and data not shown). 
CD34 molecules were also found on up to 45% of cultured 
fetal liver cells, while no expression of T cell markers uch 
as CD2, CD3, CD4, or CD8 was detected uring the cul- 
ture period. By contrast, CD7 expression increased throughout 
culture, and was detected on 63% of cells at day 15 (Table 
3). Since high proliferation of fetal liver cells was observed 
in response to ri1.2, phenotypic studies were next performed 
in cultures et up in the presence of ET-VII epithelial cells 
plus 10 nM ri1.2. Fetal iver cells growing under these cul- 
ture conditions howed proliferation kinetics imilar to those 
observed in the presence of 11.2 alone. Cellular proliferation 
also paralleled a sequential cquisition of CD45 and CD7 
molecules, which were first detected on 49 and 14% of cells, 
respectively, atday 7, and reached 94 and 53% of cells, respec- 
tively, at day 20 (Table 3, and Fig. 8). Expression of CD45 
and CD7 was followed by the acquisition of CD2 and 11. 
2Rot molecules by a variable proportion of fetal liver cells 
(17 and 15%, respectively, at day D), that increased throughout 
culture (45 and 47% of cells, respectively, atday 20) (Table 
3). Thus, after 20 d of culture, most CD45+CD7 + cells 
(85%) also expressed CD2 molecules in high levels, and some 
of them (11%) did so in low levels. As shown in Fig. 8, ex- 
pression of I1.2Rc~ was detected in the fetal iver subset shown 
to coexpress high CD2 levels. 
More importantly, all these phenotypic changes were shown 
to precede the appearance of CD3 + mature T cells in the 
cultures (12 and 31% of ceUs at days 13 and 20, respectively) 
(Table 3). Most CD3 + cells coexpressed the TCR or//3 (Fig. 
8), as assessed by staining with the BMA031 mAb (67), while 
few, if any, TCR 3,/8 + cells were detected throughout cul- 
ture (data not shown). Acquisition of the CD3-associated 
TCR cx/B complex correlated with the differentiation f fetal 
liver cells into single-positive c lls expressing high levels of 
CD4 (CD4bng ht) (Table 3). In fact, most CD4b~ ht cells 
(81%), but not the small fraction of CD4 d~ cells detected 
in these cultures, coexpressed CD3 (Table 3, and data not 
shown). As expected from the observed CD3 vs. CD4 distri- 
bution, few CD8 + cells (<2%) were detected within the 
CD3 § subset. It is also noteworthy that no expansion of 
CD8+CD3 - immature T cells was observed throughout 
culture in the presence of epithelial cells, although a small 
cell fraction (12%) displaying this phenotype was observed 
at day 20 (Table 3). Two-color flow cytometry analyses showed 
a mutually exclusive distribution of CD4 and CD8 differen- 
tiation antigens (Fig. 8). Coexpression ofboth CD4 and CD8 
molecules was never detected at any tested culture times (days 
7-20), suggesting that CD4 +CD8 + double-positive cells 
were not generated throughout culture. Accordingly, CDla 
expression, generally associated with the double-positive 
phenotype, was not found in our cultures (Table 3). Finally, 
CD14 and CD4 a~ expression was observed in a small subset 
(9%) of CD3- fetal iver cells. This suggests that, in addi- 
tion to T cell differentiation, myeloid ifferentiation was al o 
driven in cultures where epithelial cells were present. 
Figure 8. Human fetal liver hematopoietic precursors differentiate in 
vitro into CD3-TCR ol/~ + mature T cells in the presence of thymic ep- 
ithelial cells. Freshly isolated 8-wk human fetal liver cells were cocultured 
with monolayers of the ET-VII thymic epithelial cells in medium con- 
taining 10 nM rlL-2. After 20 d of culture, two-color flow cytometry 
analyses were IX-donned using the following combinations of mAbs: FITC- 
GAPS.3 (anti-CD45) and biotinilated 3A1 (anti-CD7) plus PE-streptavidin; 
FITC-OKT4 (antiqZD4) and PE-Leu-2a ( nti-CDS); BMA031 (anti-TCIL 
or//3) plus FITC-goat anti-mouse F(ab')2 IgG and PE-Leu-4 (anti-CD3); 
and FITC-MAK-108 (anti-IL-21Lcx) and Tll-RD1 (anti-CD2). Similar 
results were obtained in three independent xperiments. 
28 Human Fetal T Cell Ontogeny 
Discussion 
In the present study, phenotypic, molecular, and functional 
approaches have been used to investigate maturation events 
that occur at very early stages in human fetal T cell ontogeny. 
Flow cytometry analyses of hematopoietic cells arising in the 
liver during human embryogenesis howed that neither T 
cell-, B cell-, nor myeloid lineage-restricted markers were 
expressed by fetal iver cells before 8 wk of gestation. How- 
ever, a surprisingly high expression of the 4F2 molecule, as 
well as of certain cell adhesion receptors (including LFA-3 
and VLA-4), was detected on the surface of virtually all fetal 
liver cells at this early embryonic stage. LFA-3+VLA -
4 + 4F2 + fetal liver cells may contain multipotent hematopoi- 
etic progenitors, as those molecules are also detected on 
CD34 + hematopoietic stem cells from the human bone 
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marrow (our unpublished results). In addition, expression 
of VLA-4 molecules has also been shown in murine bone 
marrow lymphomyeloid precursors (68). Last, Tfr molecules 
were detected on a significant fraction of fetal iver cells, sug- 
gesting that they may include Tfr-bearing erythroid precursors 
and, to a lesser degree, CFU-GM progenitors (69, 70). Since 
Tfr are also expressed on the most immature human thymo- 
cytes (14), early T cell precursors, lacking lineage-restricted 
markers, may reside within the Tfr + fetal liver cell subset. 
Despite the lack of T lineage-restricted markers on fetal 
liver cells from early (7-8-wk) embryos, our molecular studies 
provided evidence that T cell-specific differentiation events 
were initiated in the human fetal iver before the time of in- 
trathymic colonization. RNA transcripts for the %/~, e, and 
~" chains of the CD3-TCR complex were consistently detected 
in variable numbers of 8-wk-old fetal iver cells. This finding 
could suggest that transcription of genes encoding all four 
invariant CD3-TCR components may occur within a discrete 
subset of putative T cell precursors. However, the possibility 
that they are independently expressed by different cell types 
cannot be formally excluded. Fetal liver prethymic T cell 
precursors have been previously identified as a minor subset 
of CD7 + cells expressing cytoplasmic CD3-e (cCD3-e) mol- 
ecules (10). However, cCD3-e expression does not prove T 
cell lineage commitment, since it can also occur in CD7 § 
immature thymocytes that display phenotypic and functional 
features of NK cells, but lack CD3-3, and CD3-/~ mRNA 
(71, and our unpublished results). Our finding in fetal iver 
of CD3-3, and CD3-/~ transcripts further supported the fact 
that certain fetal liver hematopoietic progenitors represent 
an early CD7- maturational step towards mature T cells. 
Indeed, CD7- stem cells containing T cell precursors may 
exist in vivo, since CD7-depleted cells from human bone 
marrow are still able to reconstitute allhematopoietic lineages 
(72). Our results also showed that %/~, e, and ~" gene tran- 
scription in fetal iver cells preceded the expression of TCR-ot- 
and TCR-3-rearranged genes. This gene expression pattern 
closely resembles that of intrathymic T cell precursors, which 
contain mature CD3 transcripts but not TCR-o~ or TCR-fl 
ones (14). Taken together, these data indicate that the tran- 
scription of genes coding for the invariant CD3-TCR com- 
plex components occurs early in human ontogeny in certain 
fetal iver cells, which we believe constitute prethymic T cell 
precursors. In contrast, the expression of genes encoding the 
a and ~ polymorphic subunits of the TCR appears as a 
thymus-restricted T cell maturation event. 
Parallel molecular analysis of the transcription ofgenes en- 
coding IL-2, IL-4, and their corresponding receptors allowed 
us to investigate he developmental regulation of the activa- 
tion of these cytokine pathways. As previously observed in 
the mouse (6, 9), our studies revealed that II..2 and IL.2Roe 
transcripts were absent in the human fetal iver. In contrast, 
both genes were expressed in the fetal thymus, but not in 
mature thymocytes, uggesting that they are specifically in- 
duced intrathymically in early T cell precursors. An interesting 
finding was the presence of IL-2R3 transcripts in all fetal tissues 
analyzed, including the earliest fetal liver samples. In fact, 
expression of the Ib2R~ gene was detected in most (70%) 
29 S~nchez et al. 
fetal iver cells from 8-wk-old embryos. We believe that these 
cells transcribing the IL-2R3 gene contain the proposed subset 
of fetal iver T cell precursors, and functional data using Ib2 
lend further support o this notion (see below). However, 
the quantitative r sults on the transcription ofCD3-TCK genes 
do not allow us to make absolute correlations, ince only ,040, 
35, 15, and 8% of fetal liver cells transcribed the e,/~, % 
and ~" genes, respeetivdy. These results also suggest that Ib2R3 
gene expression i fetal iver cells may reflect a common de- 
velopmental feature of hematopoietic progenitors for different 
cellular lineages. 
Molecular studies also revealed that activation of the II.-4 
pathway was induced in fetal iver at 8 wk of gestation. Since 
II:4 transcripts were detected in a low fraction (15-20%) of 
fetal iver cells (data not shown), these analyses did not reveal 
the cellular source of II.-4 gene expression within the human 
fetal iver. Therefore, primitive T cell precursors, but also other 
hematopoietic cells shown to transcribe the II.~4 gene (such 
as basophils and mast cells; 73), may be included in the Ib4- 
producing fetal liver cell subset. 
Additional evidence that primitive T cell precursors were 
indeed present in the human fetal liver as early as 8 wk of 
gestation was provided by functional in vitro studies howing 
that fetal iver hematopoietic cells were able to proliferate and 
to differentiate along the T cell lineage. Cell proliferation 
was sustained by IL-2, as well as IL-4, for at least 5 wk. These 
studies, however, did not address whether asingle fetal iver 
subpopulation is responding to both cytokines or, alterna- 
tively, different hematopoietic precursors selectively respond 
to particular soluble mediators through the corresponding 
specific receptors. In favor of the last possibility, we have 
observed that phenotypically distinct fetal iver cells proliferated 
in response to IL-2 or Ib4. IL-4-induced growth paralleled 
the appearance in vitro of cells expressing myeloid-associated 
antigens. This finding supports the proposed role of IL4 as 
a stimulatory factor for myeloid precursors (74). IL-2-pro- 
liferating cells, however, mostly acquired CD7 and CD8 T 
cell markers, and some of them also expressed CD2 mole- 
cules. Interestingly, similar CD8 + single-positive immature 
T cells have been characterized in the rat and mouse thymus 
as the immediate precursors of CD4 § CD8 + double-positive 
cortical thymocytes (75). The immature T cell phenotype 
of the fetal iver cells proliferating to I1.-2, together with the 
finding that most of them, as shown in intrathymic T cell 
precursors (15), expressed the ID2R3, further suggests that 
precursors of the T cell lineage are included in the Ib2RB + 
subpopulation detected in the early human fetal liver. 
The preferential differentiation of CD7 + cells at the ex- 
pense of CD14 § and CD4 dull cells observed in II~2-driven 
cultures could indicate that, in vivo, availability of IL-2 by 
primitive fetal liver T cell precursors may be important in 
tilting the T lymphoid vs. myeloid differentiation balance. 
However, terminal differentiation ffetal iver precursors into 
mature T cells was never observed in vitro upon culture with 
Ib2 and, therefore, other signals provided by the thymic 
microenvironment may be involved in the process. Accord- 
ingly, mature CD3-TCR o~/3 + T cells appeared in our cub 
tures when thymic epithelial cells (ET-VII) were provided. 
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The lack of both TCR ot and TCK 3 transcripts in 8-wk 
fetal liver cells directly analyzed ex vivo by PCR provided 
evidence that new genetic programs were initiated in vitro 
in fetal iver precursors after coculture with thymic epithelial 
cells, and formally ruled out a possible outgrowth of a small 
contaminating subset of mature T cells. In addition, they 
could suggest the functional implication of the II.-2 pathway 
in the proliferation and the initiation of the T cell differenti- 
ation program in early thymic immigrants coming from the 
liver. However, the recent observation of phenotypically ma- 
ture T cell populations in I1,2-deficient mice (76) indicates 
that I1.-2 is neither sufficient, nor essential, for T lympho- 
cyte development and, therefore, other cytokines produced 
in the thymus may functionally replace the missing I1,2. The 
inductive signals involved in the differentiation program ob- 
served in vitro appeared to be delivered upon close cell-to- 
cell interactions, rather than by epithelium-derived soluble 
mediators, ince cytokines produced by the ET-VII epithelial 
cells, including I1,3, I1,6, and IL.7, failed to induce the differen- 
tiation of fetal liver cells into mature CD3-TCK + lympho- 
cytes. Neither did those cytokines induce differentiation of
CD3-TCR + mature T cells in the presence of thymic epi- 
thelial cells, although acquisition of some T cell markers, uch 
as CD7 and I1,2Ro~, was detected in those cultures, as well as 
in cultures et up in the presence of thymic epithelium without 
exogenous cytokine supplementation ( ur unpublished results). 
These data are in agreement with previously reported ata 
on the important role that interaction with the thymic epi- 
thdium plays in the induction of the I1,2Kc~ gene (7). 
Finally, the absence of detectable CD8+CD4 + double- 
positive calls at different ime points from the onset of our 
cultures would suggest that this subset does not significantly 
contribute to the generation of TCK cffB-expressing ma- 
ture T cells from fetal liver precursors. However, the possi- 
bility that a small number of double-positive c lls, not de- 
tected in our study, do serve as T call progenitors cannot 
be excluded considering that most cells within the double- 
positive subset die rapidly in culture, as they do in vivo (77). 
Another important question is whether the requirements for 
the generation of CD4 + or CD8 + single-positive mature T
cells are different. This seems very likely in view of our results 
showing that differentiation f CD4 + ceils is preferentially 
driven in our culture conditions. As previously proposed (47, 
49), this could reflect he existence of functionally distinct 
types of epithelial cells within the thymic microenvironment, 
influencing the differentiation f T cell precursors into a given 
T cell subset. Establishment ofphenotypically and function- 
ally distinct subpopulations of thymic epithelial cells may pro- 
vide a useful experimental system to approach this question 
in the near future. 
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